Structure of the SARS-CoV-2 RNA-dependent RNA polymerase in the presence of favipiravir-RTP.
Naydenova, K., Muir, K.W., Wu, L.F., Zhang, Z., Coscia, F., Peet, M.J., Castro-Hartmann, P., Qian, P., Sader, K., Dent, K., Kimanius, D., Sutherland, J.D., Lowe, J., Barford, D., Russo, C.J.(2021) Proc Natl Acad Sci U S A 118
- PubMed: 33526596 
- DOI: 10.1073/pnas.2021946118
- Primary Citation of Related Structures:  
7AAP - PubMed Abstract: 
The RNA polymerase inhibitor favipiravir is currently in clinical trials as a treatment for infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), despite limited information about the molecular basis for its activity. Here we report the structure of favipiravir ribonucleoside triphosphate (favipiravir-RTP) in complex with the SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) bound to a template:primer RNA duplex, determined by electron cryomicroscopy (cryoEM) to a resolution of 2 ...